foxo4 dri peptide senolytic 2024 study

foxo4 dri peptide senolytic 2024 study FOXO4-DRI: Human Trial Status, Cancer Research & Data Senolytic Peptide FOXO4-DRI Selectively Removes

Name: foxo4 dri peptide senolytic 2024 study FOXO4-DRI: Human Trial Status, Cancer Research & Data Senolytic Peptide FOXO4-DRI Selectively Removes
Brand: cantondelareina.com.ar
SKU: 6652614008
Price: 27.69 USD
Availability: InStock
Rating: 4.4509 (9 reviews)

Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PMC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 6652614008 · From cantondelareina.com.ar

4.5

USD27.69 USD77.69

Pay in 4 interest-free payments of $6.92 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 16 - Sep 21

Description

Brain Res 325:317321 Zee EA van der, Benoit R, Strosberg AD, Luiten PG (1991) Coexistence of muscarinic acetylcholine receptors and somatostatin in nonpyramidal neurons of the rat dorsal hippocampus